EdgeMarketInstruments › BCAB

BCAB — BioAtla, Inc.

US Healthcare Pharma & biotech equity mkt cap 201.8M
3.18 +0.00% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 3.06 · high 61.00

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2020-12-16.

Performance

1 day+0.00%
1 week+2.91%
1 month-8.09%
3 months-12.03%
6 months-62.68%
Year to date-88.09%
1 year-83.06%
3 years-97.51%
5 years-99.85%

Technicals

RSI 1446.6
vs 50-day avg-11.68%
vs 200-day avg-76.52%
Volatility 1y133.7%
Max drawdown 1y-94.98%
Avg volume 30d52.6K
Daily bars held1,426
History from2020-12-16

Measured signals that fired on BCAB

datesignal measured base rate
2026-03-04Short volume far above its own normal
short
-0.76% over 21 days · t = -2.79 · n = 5,897
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-05-31SHORT JAY M PHD
Chief Executive Officer
Shares withheld for tax2593.931.0K
2026-05-31Sievers Eric
Chief Medical Officer
Shares withheld for tax1343.93527
2026-05-31Vasquez Christian
Chief Financial Officer
Shares withheld for tax823.93322
2026-03-12SHORT JAY M PHD
Chief Executive Officer
Shares withheld for tax6390.17107
2026-03-11Sievers Eric
Chief Medical Officer
Shares withheld for tax3600.1761
2026-03-11Vasquez Christian
Chief Financial Officer
Shares withheld for tax1750.1730
2026-03-11SHORT JAY M PHD
Chief Executive Officer
Grant or award430.0K0.000
2026-03-10Vasquez Christian
Chief Financial Officer
Grant or award240.0K0.000
2026-03-10Sievers Eric
Chief Medical Officer
Grant or award240.0K0.000
2026-02-28SHORT JAY M PHD
Chief Executive Officer
Shares withheld for tax7.7K0.251.9K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
ACORN CAPITAL ADVISORS, LLC865.0K5.4M
MILLENNIUM MANAGEMENT LLC443.8K2.8M
VANGUARD CAPITAL MANAGEMENT LLC265.5K1.6M
GEODE CAPITAL MANAGEMENT, LLC111.0K689.2K
DEUTSCHE BANK AG\84.1K525.4K
RENAISSANCE TECHNOLOGIES LLC82.2K510.5K
BlackRock, Inc.77.4K480.9K
CITADEL ADVISORS LLC70.1K435.7K
UBS Group AG60.5K375.6K
MARSHALL WACE, LLP44.4K277.6K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
10-Q2026-08-132026-06-30on EDGAR ↗
8-K2026-07-162026-07-16on EDGAR ↗
42026-06-052026-03-11on EDGAR ↗
42026-06-052026-03-12on EDGAR ↗
42026-06-052026-03-11on EDGAR ↗
ARS2026-06-032025-12-31on EDGAR ↗
DEFA14A2026-06-03on EDGAR ↗
DEF 14A2026-06-032026-06-03on EDGAR ↗

Short selling

Avg short volume, 90d42.8% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about BCAB

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open BCAB in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →